HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Archives for Government

NPC: CMS Proposed Rule Hinders Value-Based Arrangements

In a letter to the Centers for Medicare and Medicaid Services, the National Pharmaceutical Council (NPC) outlines some key issues with the agency's recently-proposed rule. NPC says the proposal "poses a barrier to implementing value-based arrangements and hinders innovation in payment and […]

more info 07/23/2020View Related Articles
Bookmark and Share

Shulkin: COVID-19 Laying Foundation for ‘Tsunami of Challenges’ for Health System

CMS_fundingopportunity

David Shulkin, former secretary of the Department of Veterans Affairs, says the COVID-19 crisis is ultimately generating a "tsunami of challenges for the health system." In a recent guest piece published on Healthcare Dive, Shulkin points to key long-term issues, including Medicaid […]

more info 07/23/2020View Related Articles
Bookmark and Share

Datta: CMS Proposal a ‘Grab-bag of Issues’

CMS_fundingopportunity

Sidley Austin LLP's Meena Datta told HealthLeaders that the Centers for Medicare and Medicaid Services' (CMS) latest proposal is a "grab-bag of issues." Datta said the proposal, which looks to ease regulations on value-based deals, addresses issues for which the health industry has long sought […]

more info 07/21/2020View Related Articles
Bookmark and Share

Zemcik, Fry Spotlight CMS Best Price Proposal

Commercial Solutions' Rick Fry and TrialCard's Jason Zemcik spotlight the Centers for Medicare and Medicaid Services' best price proposal in a recent Drug Channels post. "This Proposed Rule is sure to generate significant discussion on both sides of the issue," they write. "How CMS will […]

more info 07/15/2020View Related Articles
Bookmark and Share

Bach Outlines ‘Gaping’ Loophole in Medicaid Proposal

CMS_fundingopportunity

A Centers for Medicare and Medicaid Services proposal includes a "gaping" loophole through which drugmakers could avoid selling drugs to Medicaid for the lowest possible price, Peter Bach writes in a Health Affairs Blog post. The proposal, he writes, opens the door for drugmakers to exploit […]

more info 07/15/2020View Related Articles
Bookmark and Share

Opinion: Discuss Price for COVID-19 Vaccine Now, Not Later

The U.S. should begin pricing discussions for a COVID-19 vaccine before we get "stuck paying dearly for shots that the rest of the world will get much cheaper," the author of a recent opinion piece published in The New York Times writes. Elisabeth Rosenthal, author and editor and chief of Kaiser […]

more info 07/13/2020View Related Articles
Bookmark and Share

Article: Researchers Point to Germany’s Model for Purchasing Cancer Drugs

Researchers say U.S. policymakers should look to Germany's drug purchasing model to try and better align cancer drug prices with their clinical benefits, according to a STAT Pharmalot article. According to the article, Germany's model ultimately led to a 25 percent drop in prices one year […]

more info 07/13/2020View Related Articles
Bookmark and Share

Report: European Drug Regulatory Network Faces Uncertain, Complex Future

A new strategy produced by European regulators considers future challenges for the European drug regulatory network, The Pink Sheet reports. The plan, per the report, looks to position the regulatory network to endure an uncertain future. To read the report, click here. […]

more info 07/09/2020View Related Articles
Bookmark and Share

Study Finds Inconsistent Reimbursement Assessments Across EU Markets

While some modifications in the HTA process for orphan drugs have had some positive impacts, manufacturers still face key hurdles due to inconsistent reimbursement assessments in the EU markets, the authors of a recent study suggest. The authors, Chales River Associates' Steven Kelly, Ioanna […]

more info 07/02/2020View Related Articles
Bookmark and Share

Report: FDA Mandates 50% Efficacy for COVID-19 Vaccines

Vaccine candidates must be at least 50 percent more effective than a placebo to be considered for Food and Drug Administration approval, according to a FiercePharma report. However, some experts have expressed concerns about that guidance, according to the report, with some suggesting that level […]

more info 06/30/2020View Related Articles
Bookmark and Share

Proposed Medicaid Changes Aim to Foster Innovative Contracts

CMS_fundingopportunity

The Centers for Medicare and Medicaid Services (CMS) is hoping to encourage greater use of innovative contracting models in a recently-proposed package of changes to Medicaid. Washington University in St. Louis associate law professor Rachel Sachs in a recent Health Affairs blog post writes that […]

more info 06/27/2020View Related Articles
Bookmark and Share

Legislation Aims to Prevent Pharma From Price-gouging During Pandemic

Two new bipartisan bills introduced by House Democrats aim to prevent the pharmaceutical industry from engaging in price-gouging on COVID-19 treatments, according to a Common Dreams report. The legislation was introduced following a recent poll that found a whopping 88 percent of Americans fear […]

more info 06/24/2020View Related Articles
Bookmark and Share

Report Reveals Racial Disparities in COVID-19 Outcomes

New data released by the government on Monday suggests black Americans under Medicare were roughly four times more likely as white Americans to be hospitalized for COVID-19, Reuters reports. The data was released by the Centers for Medicare and Medicaid Services. "The disparities in the data […]

more info 06/24/2020View Related Articles
Bookmark and Share

Hahn: Some COVID-19 Changes to Remain

Food and Drug Administration (FDA) Chief Stephen Hahn recently said some changes made to address COVID-19 will remain in place, Medical Design & Outsourcing reports. Hahn made the comments June 19 during a meeting with members of the Medical Device Innovation Consortium, according to the […]

more info 06/24/2020View Related Articles
Bookmark and Share

Blog Post Touts VA, ICER Partnership as ‘Highly Beneficial’

The partnership between the Department of Veterans Affairs (VA) and the Institute for Clinical and Economic Review (ICER) has provided benefits across a number of fronts, according to a Health Affairs blog post by representatives of the agency and drug pricing watchdog. Despite concerns that the […]

more info 06/22/2020View Related Articles
Bookmark and Share

Report: EMA Considers Big Data Network ‘Priority’

The European Medicines Agency (EMA) says the development of a big data network is a "priority" project, according to a Pink Sheet report. According to the report, the agency's 2019 report offered some insight into plans for a new data network. To read the full report on The Pink Sheet, click […]

more info 06/17/2020View Related Articles
Bookmark and Share

Report: Hospitals Paid CEO Millions While Laying Off Thousands

Despite having received billions in emergency funds through the CARES Act, some of the nation's top hospital systems have been laying off thousands while paying their top executives millions, The New York Times reports. The New York Times combed through tax and securities filings by the top 60 […]

more info 06/10/2020View Related Articles
Bookmark and Share

OptumRx: Payers Should Monitor Three Key Drugs

OptumRx in its latest drug pipeline update recommends payers to keep an eye on risdiplam, viltolarsen and trodelvy, FierceHealthcare reports. OptumRx's chief medical officer, Sumit Dutta, says orphan drugs could account for roughly 40 percent of approvals by the Food and Drug Administration this […]

more info 06/08/2020View Related Articles
Bookmark and Share

Trump Administration Picks Five Companies in Operation Warp Speed

The Trump administration has selected five drugmakers as being most likely to develop a coronavirus vaccine, The New York Times reports. According to the report, the five companies are Moderna, a partnership between Oxford University and AstraZeneca, Johnson & Johnson, Merck and […]

more info 06/07/2020View Related Articles
Bookmark and Share

A Look at How Germany Structures Drug Purchasing

James Robinson in a recent perspective piece published in NEJM looks at how Germany purchases medicines. Germany's system, he writes, not only incentivizes agreements but also restricts price increases if there exists no evidence-based justification. To read the write up, click here. (Paid […]

more info 06/05/2020View Related Articles
Bookmark and Share

FDA Chief Vows to Permanently Adopt COVID-19 Measures to Accelerate R&D

Food and Drug Administration (FDA) Commissioner Stephen Hahn in a recent speech said the agency will work toward permanent adoption of COVID-19 measures aimed at accelerating research and development, FierceBiotech reports. "To the extent that innovations and adaptations we implemented during the […]

more info 06/03/2020View Related Articles
Bookmark and Share

CMS Implements Harsher Penalties for Nursing Homes Amid Pandemic

The Centers for Medicare and Medicaid Servicies (CMS) is implementing stiffer penalties for nursing homes which are repeatedly caught violating infection control protocol, FierceHealthcare reports. According to the report, as of May 24, some 26,000 COVID-19 deaths were individuals in nursing […]

more info 06/02/2020View Related Articles
Bookmark and Share

EMA Calls for Transparency, Collaboration in COVID-19 Studies

The European Medicines Agency (EMA) is urging transparency and collaboration on COVID-19 studies to facilitate more robust results. "High-quality observational research of real world data collected during the pandemic can be an important complement to the results of randomised clinical trials in […]

more info 06/01/2020View Related Articles
Bookmark and Share

A Look at Phlow CEO’s Track Record

STAT in a recent report takes a look at the track record of Phlow CEO Eric Edwards, who the Trump administration tapped to manufacture generic drugs in short supply. According to the report, Kaleo, which was founded by Edwards and his brother, hiked the price of its opioid overdose drug, Evzio, […]

more info 05/24/2020View Related Articles
Bookmark and Share

Will Expanded Access to Telehealth Services Stay Put?

While the Trump administration's sweeping reimbursement changes led to expanded telehealth services and access, some are concerned about their longevity, Fierce Healthcare reports. "We are concerned about what will happen post-COVID if changes prevent us from providing telehealth at patients' […]

more info 05/22/2020View Related Articles
Bookmark and Share

Putting a Dollar Amount on Human Life

Austin Frakt in a recent article published in the New York Times outlines how governments have tackled the issue of applying a dollar figure to human life. "There has always been a limit to how much we are willing to spend to protect life and health," he writes. "After all, no society can spend a […]

more info 05/16/2020View Related Articles
Bookmark and Share

EMA Reportedly Preparing Q&A Guidance on Big Data

The European Medicines Agency (EMA) is reportedly preparing new guidance on the application of EU data rules for secondary use of health data, according to a Regulatory Affairs Professionals Society report. According to the report, EMA is working to finalize the guidance next year. "The aim is […]

more info 05/13/2020View Related Articles
Bookmark and Share

Article: Health Jobs No Longer Recession Proof

While health care jobs have been generally considered recession-proof, the COVID-19 pandemic is breaking that trend, according to a recent article published in The New York Times. Job losses in the health care industry, according to the article, reached 1.4 million in April. "This is a […]

more info 05/11/2020View Related Articles
Bookmark and Share

Article Highlights FDA Decisions that Involved RWE

A recent article published on Aetion looks at three recent decisions by the Food and Drug Administration (FDA) that included real-world evidence. The article outlines how RWE supported the approval of Pretomanid, Zolgensma and Lutathera. "The U.S. Food and Drug Administration (FDA) is […]

more info 05/01/2020View Related Articles
Bookmark and Share

Aetion Launches FDA Decision Alerts

Aetion announced the launch of a new library of FDA submissions that used real-world data and real-world evidence, the FDA Decision Alerts. "To enable our partners to learn from the growing empirical evidence base of regulatory decisions, Aetion is systematically assessing drug and biologic […]

more info 04/29/2020View Related Articles
Bookmark and Share

  • 1
  • 2
  • 3
  • …
  • 40
  • Next Page

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • How Healthy Are Your Market Access Programs? A guide to performing check-ups on pharmaceutical distribution and patient access programs
  • Data removes the barriers to understanding rare disease
  • The Future Was Today
  • How Can a Supply Chain Dashboard Yield Greater Clinical Trial Insights, Cost Control, and Efficiency?
  • Strategies for Engaging Vulnerable Populations in Healthcare
  • Tracing the health care experience informs decision-making
  • Driving More Value and Cost Savings With SDOH Data
  • Advancing Early Stage Oncology Research with Adaptive Designs and Master Protocols
  • Transformation of Clinical Trial Design and Operations
  • Using real-world data to close the rare disease data gap
  • Analysis and Insights from Real-World Clinical Registries: RA, GCA, JIA, & SLE
  • The role of real-world evidence in FDA approvals
  • Cytel Scientists Call for a “Statistician-First Workflow” to Optimize Drug Development
  • Specialty Pharmacy Virtual Technology Adoption on the Rise
  • Clinical Trials Have Changed. Has Your Tech Strategy?
  • Beyond COVID-19: Life sciences reimagined
  • How Real-World Evidence Can Support Adoption of New Technology
  • Interventional Studies
  • Virtual Expanded Access Program Providing Breast Cancer Patients Early Access to Treatment During the COVID-19 Pandemic
  • Pediatric Drug Development: Trends and Perspectives in the United States
  • Can Clinical Studies Go Virtual?
  • ICER’s impact on payer decision making
  • Representation and Diversity in Clinical Trials
  • Advisory Boards: The Good, The Bad, and The Ugly
  • An Initial Framework to Describe and Classify Integrated Scientific Advice Procedures
  • Ensuring timely dissemination of research: a guide to working as a medical publications professional
  • Patient Intelligence and Insights Reports
  • Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines
  • Patient Centricity
       Exploring the patient dynamic from different perspectives
  • How to Excel at Next Generation Trial Execution

Syndicated Reports

  • Bioinformatics Market Research Report by Product, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19
  • Health Economics & Outcomes Research (HEOR) Services Market to 2027
  • Healthcare Artificial Intelligence Market by Product and Services – Global Forecast to 2027
  • Bioinformatics Market – Growth, Share, Opportunities & Competitive Analysis, 2020 – 2028
  • Big Data and AI in Market Access
  • Altruista Health Payer Index Survey 2020 Report
  • Innovations in Drug Pricing and Reimbursement 2020
  • Healthcare Reimbursement Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026
  • Real World Data for Orphan Drugs: Meeting the Data Analysis Challenge
  • Directory of Health Plans: Trusted Health Insurance Plan Enrollment and Affiliation Data
  • Global Value-Based Reimbursement Software Market Report
  • Health Economics & Outcomes Research (HEOR) Services Market: Emerging industries, Challenges and Threats Faced by Key Vendors(Axtria, Avalon Health Economics, Cardinal Health, ICON, IQVIA, McKesson, MEDLIOR, Optum, PharmaLex, (PPD), RTI)
  • World Preview 2019, Outlook to 2024
  • Provider Perceptions of Value-Based Care
  • Healthcare Industry’s Response to COVID-19
  • Value-Based Care Assessment
  • Pharmacy Benefit Management Market in US – Industry Outlook and Forecast 2020-2025
  • 2025 Growth: Healthcare Reimbursement Market set to grow with massive rate by 2020 to 2025
  • Global Specialty Pharmaceutical Market 2020- Pfizer, Roche, Amgen, AbbVie
  • 3 Trends to Accelerate Time to Market
  • Scientific Research And Development Services Global Market Report 2020-30: Covid 19 Impact and Recovery
  • Engaging with ICER: Lessons and insights for pharma
  • COVID-19 Implications for pharma: US payer insights
  • Pricing and Reimbursement in Oncology
  • Digital Technologies: New Strategies for Customer Engagement
  • Real World Evidence (RWE) Solutions Market by Component, Application, End User – Global Forecast to 2024
  • 2019 Healthcare Benchmarks: Social Determinants of Health
  • Pricing Transparency in Pharma
  • Medical Affairs: The Roadmap to 2025
  • Health Economics & Outcomes Research (HEOR) Services Market Share & Forecast, 2020–2026
HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • HealthEconomics.Com Recognized as Top Influencer at ISPOR International Meeting in Washington DC
  • Will ICER Framework Destroy Progress Against Multiple Myeloma?
  • Celgene Unleashes the Power of Data into Clinical Trial Design
  • How Well is Harvoni Working in the Real World?
  • New CVS and Express Scripts Value Based Plans for Oncology
  • Oversized Cancer Drug Vials Waste $3B Each Year
  • Can More Data Make Providers’ Jobs Easier?
  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Take This Survey for a Chance to Win $200!
  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • ICER Releases Two Draft Reports on Obeticholic Acid
  • What do Patient Advocates Think of New ICER Report?
  • Could a New ICER Report Put Patients at Risk?
  • Contact Us

About

  • International Myeloma Foundation Responds to ICER Report
  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • Doctor Evidence Launches GROWTH Replicator Program
  • Is PCORI Underfunding CER?
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute